How Incyte Beat Wall Street Estimates in Q4
Incyte (NASDAQ: INCY) delivered a strong performance in 2019, with its shares soaring 37%. The biotech's momentum has faded so far this year, though.
However, Incyte gave investors a reason to cheer with its fiscal 2019 fourth-quarter and full-year results announced before the market opened on Thursday. Here are the highlights from the company's Q4 update.
Image source: Getty Images.
Source Fool.com
